In a groundbreaking study published in Nature Communications, researchers at Kyushu University have unveiled new insights into ferroptosis, a unique form of programmed cell death that is iron-dependent and driven by lipid peroxidation. This recent discovery sheds light on the vital role lysosomal lipid peroxidation plays in initiating ferroptosis, a finding that could dramatically impact the future of cancer therapeutics and other disease treatments linked to cell death regulation.
Programmed cell death, an essential physiological process, maintains cellular homeostasis and organismal health by eliminating damaged or unwanted cells. Among the various modalities of cell death, ferroptosis stands out due to its distinct mechanism relying on iron-mediated oxidation of lipids within the cell’s phospholipid membranes. Unlike apoptosis or necrosis, ferroptosis involves an accumulation of lipid peroxides, which destabilizes membranes and leads to irreversible cell damage. However, certain cancer cells demonstrate resistance to ferroptosis, posing a major hurdle in using this mechanism as a therapeutic tool.
The Kyushu University team addressed this challenge by focusing on the lysosomes, cellular organelles responsible for degradation and recycling of biomolecules. By employing state-of-the-art imaging techniques that allowed visualization of lipid radical formation within live cells, the researchers detected that lipid peroxidation predominantly initiates within lysosomes during ferroptosis. This crucial finding suggests that lysosomal membranes are the primary sites of oxidation damage that triggers the cascade culminating in cell death.
Further investigations revealed that oxidized lysosomal membranes become permeabilized, allowing iron stored within lysosomes to leak into the cytoplasm. This iron release acts as a catalyst, amplifying lipid peroxidation in other intracellular membranes. Such propagation intensifies ferroptotic signals, reinforcing the destructive cycle and ensuring effective execution of cell death. This mechanistic insight offers a new layer of understanding about how ferroptosis systematically destabilizes cellular integrity.
Interestingly, the study highlights a paradox observed in ferroptosis-resistant cancer cells: although lipid peroxidation does occur within their lysosomes, it does not lead to membrane permeabilization or iron leakage. This resistance prevents the downstream amplification of ferroptotic signals, enabling these cancer cells to survive despite oxidative stress. Understanding this resistance mechanism became a central quest for the Kyushu researchers aiming to surmount therapeutic barriers.
A pivotal breakthrough came when the team tested chloroquine, an anti-malarial drug known to compromise lysosomal membrane integrity. Remarkably, treating ferroptosis-resistant cells with chloroquine induced lysosomal membrane permeabilization, promoting iron leakage and thereby sensitizing these cells to ferroptosis. This discovery points to a promising strategy for overcoming ferroptosis resistance by pharmacologically targeting lysosomal stability.
Professor Ken-ichi Yamada, who led the study at Kyushu University’s Faculty of Pharmaceutical Sciences, remarked, “Our findings redefine the hierarchy of events in ferroptosis, placing lysosomal lipid peroxidation and membrane permeabilization at its core. This not only broadens our understanding of cell death pathways but also opens new therapeutic avenues especially for cancers that evade traditional treatments by resisting ferroptosis.”
The implications of this research extend far beyond oncology. Ferroptosis has been implicated in a spectrum of diseases including neurodegeneration, ischemia-reperfusion injury, and certain inflammatory conditions. The ability to modulate lysosomal membrane permeabilization and iron leakage could thus serve as a universal lever to control ferroptotic cell death in various pathological contexts.
Moreover, the study underscores the importance of investigating intracellular lipid radicals and their spatial dynamics, which until recently remained challenging due to a lack of suitable detection methods. By pioneering techniques to visualize lipid peroxidation specifically within lysosomes, Kyushu’s team has provided a valuable toolset for future explorations into oxidative cell death.
While chloroquine’s role in sensitizing resistant cells is promising, the exact molecular underpinnings of why some cells maintain lysosomal membrane integrity despite lipid peroxidation remain elusive. Professor Yamada emphasizes that “identifying the protective mechanisms in ferroptosis-low-susceptible cells is vital for designing targeted therapies that minimize off-target effects and maximize clinical benefits.”
The discovery also raises fascinating questions about the interplay between lysosomal function and ferroptosis regulation. Lysosomes, traditionally viewed as mere recycling centers, emerge from this study as critical determiners of cell fate through their influence on lipid oxidation and iron homeostasis. This paradigm shift challenges scientists to reevaluate lysosomal roles in cellular metabolism and death.
Ferroptosis represents a double-edged sword: while it offers a powerful means to eliminate cancer cells, unchecked ferroptosis can contribute to tissue damage in diseases like neurodegeneration. Thus, the ability to finely tune lysosomal lipid peroxidation and membrane stability could become a cornerstone for both promoting beneficial cell death and preventing pathological destruction.
The Kyushu University research illuminates a novel dimension of ferroptosis, accentuating the lysosomal membrane as a prime target for therapeutic innovation. Their work encourages the development of drugs that specifically induce lysosomal membrane permeabilization, potentially overcoming resistance mechanisms that have hindered ferroptosis-based cancer therapies.
Future directions for this research include detailed exploration of lysosomal membrane proteins and lipid constituents that confer resistance or susceptibility to peroxidation, as well as the design of combination therapies leveraging chloroquine analogs with ferroptosis inducers. Such efforts will not only refine cancer treatment paradigms but may also inform strategies to manage a broader spectrum of ferroptosis-involved diseases.
In summary, the comprehensive investigation by Kyushu University researchers reveals that lysosomal lipid peroxidation and consequent membrane permeabilization are indispensable for the efficient induction of ferroptosis. By facilitating iron leakage into the cytosol, lysosomes orchestrate a self-amplifying lipid peroxidation cascade culminating in cell death. The innovative approach of repurposing chloroquine to disrupt lysosomal membranes in resistant cancer cells provides a promising therapeutic avenue to exploit ferroptosis in cancer treatment.
As the global scientific community seeks to harness ferroptosis for clinical benefit, these findings redefine the cellular landscape where ferroptosis unfolds and pave the way for targeted interventions that could revolutionize how we combat resistant cancers and other diseases characterized by dysregulated cell death.
Subject of Research: Animals
Article Title: Lysosomal lipid peroxidation contributes to ferroptosis induction via lysosomal membrane permeabilization
News Publication Date: 14-Apr-2025
Web References:
- DOI: 10.1038/s41467-025-58909-w
- Kyushu University: https://www.kyushu-u.ac.jp/en/
- Faculty of Pharmaceutical Sciences: https://www.phar.kyushu-u.ac.jp/en/
- Professor Ken-ichi Yamada Lab: https://bukka.phar.kyushu-u.ac.jp/
References:
Saimoto, Y., Kusakabe, D., Morimoto, K., Matsuoka, Y., Kozakura, E., Kato, N., Tsunematsu, K., Umeno, T., Kiyotani, T., Matsumoto, S., Tsuji, M., Hirayama, T., Nagasawa, H., Uchida, K., Karasawa, S., Jutanom, M., & Yamada, K.-i. (2025). Lysosomal lipid peroxidation contributes to ferroptosis induction via lysosomal membrane permeabilization. Nature Communications. https://doi.org/10.1038/s41467-025-58909-w
Image Credits: Yamada Lab/Kyushu University; Created in BioRender; Yuma, S. (2025)
Keywords: ferroptosis, lysosomal lipid peroxidation, lysosomal membrane permeabilization, iron leakage, lipid radicals, chloroquine, cancer therapy resistance, programmed cell death, lipid peroxidation visualization, oxidative stress, lysosome function, therapeutic targets
